Axelus Pharma Private Limited
About Axelus Pharma Private Limited
Data last updated:
Axelus Pharma Private Limited is a private limited company based in Ankleshwer, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2018PTC105580. Its GSTIN is 24AARCA6705G1ZN (Gujarat).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors including Mukeshbhai Kanubhai Pokiya and Ghanshyambhai Manubhai Bhesaniya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 3401/A Phase – 3 G.I.D.C Panoli, Ankleshwer, Gujarat, India – 394115.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.45 Cr, a growth of 55% compared to the previous year. For the same year it recorded a net profit of ₹1.52 Lakh (net margin 0.4%) and EBITDA of ₹54.41 Lakh (EBITDA margin 15.7%).
As per MCA filings, the company has open charges of ₹4.92 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 3401/A Phase – 3 G.I.D.C Panoli, Ankleshwer, Gujarat, India – 394115
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Axelus Pharma Private Limited
The main business activity of Axelus Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Axelus Pharma Private Limited FY 2025 filings available
Axelus Pharma Private Limited reported revenue of ₹3.45 Cr (up 55% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Axelus Pharma Private Limited
Revenue rose 55% in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Axelus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹54.41 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.52 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Axelus Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Axelus Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Axelus Pharma Private Limited
Axelus Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pharmed Medicare Private Limited | ₹3.47 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Bangalore, Karnataka, India |
| Antila Wellness Private Limited | ₹3.47 Cr (FY 2025) | •••• | •••• | -28.0% | •••• | Sanand, Gujarat, India |
| Sanum Sanguineas Solutions Private Limited | ₹3.46 Cr (FY 2025) | •••• | •••• | -57.0% | •••• | Chennai, Tamil Nadu, India |
| Radicals Pharma Private Limited | ₹3.46 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Ambala Cantt, Haryana, India |
| P.S Surgical Private Limited | ₹3.46 Cr (FY 2024) | •••• | •••• | -34.0% | •••• | Raipur, Chhattisgarh, India |
| Axelus Pharma Private Limited this company | ₹3.45 Cr (FY 2025) | •••• | •••• | 55.0% | •••• | Ankleshwer, Gujarat, India |
| Aaltop Healthcare Private Limited | ₹3.45 Cr (FY 2025) | •••• | •••• | -39.0% | •••• | Thane, Maharashtra, India |
| Osren Healthcare Private Limited | ₹3.45 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | New Delhi, Delhi, India |
| Medyssey India Private Limited | ₹3.44 Cr (FY 2024) | •••• | •••• | 109.0% | •••• | Chennai, Tamil Nadu, India |
| Seamac Formulations Private Limited | ₹3.44 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Talwara, Punjab, India |
| Genip Formulations Private Limited | ₹3.44 Cr (FY 2025) | •••• | •••• | 512.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Axelus Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Axelus Pharma Private Limited
Axelus Pharma Private Limited is audited by D K SHELADIA & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| D K SHELADIA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Axelus Pharma Private Limited
Axelus Pharma has 6 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukeshbhai Kanubhai Pokiya | Director | 12 Dec 2018 | 7 Years 10 Months | Current |
| Ghanshyambhai Manubhai Bhesaniya | Director | 12 Dec 2018 | 7 Years 10 Months | Current |
| Dhavalkumar Maganbhai Dobariya | Director | 12 Dec 2018 | 7 Years 10 Months | Current |
| Haribhai Popatbhai Kukadiya | Director | 10 Apr 2024 | 2 Years 6 Months | Current |
| Rajeshbhai Dhirajlal Devani | Director | 21 Jan 2019 | 7 Years 8 Months | Current |
| Bhailalbhai Khodabhai Bhesaniya | Director | 21 Jan 2019 | 7 Years 8 Months | Current |
Ownership and Shareholding of Axelus Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Axelus Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2021 | Others | ₹1.9 Cr | Open |
| 03 Mar 2021 | Others | ₹3.01 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Axelus Pharma Private Limited
Employment history and EPFO contributions of people linked to Axelus Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Axelus Pharma Private Limited
Axelus Pharma Private Limited has 7 board changes on record since 2018: 6 appointments and 1 cessation. The latest: Haribhai Popatbhai Kukadiya ceased to be Additional Director on 29 Sep 2024.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Axelus Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Axelus Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Axelus Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Axelus Pharma Private Limited
Axelus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AARCA6705G1ZN | Gujarat | Active | 08 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Axelus Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axelus Pharma Private Limited
Axelus Pharma is an active private limited company based in Ankleshwer, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 December 2018 (8+ years old) and is registered under CIN U24239GJ2018PTC105580.
Axelus Pharma reported revenue of ₹3.45 Cr for FY 2025 (up 55% YoY).
Axelus Pharma has 6 current directors:
- Mukeshbhai Kanubhai Pokiya - Director
- Ghanshyambhai Manubhai Bhesaniya - Director
- Dhavalkumar Maganbhai Dobariya - Director
- Haribhai Popatbhai Kukadiya - Director
- Rajeshbhai Dhirajlal Devani - Director
- Bhailalbhai Khodabhai Bhesaniya - Director
Axelus Pharma reported a net profit of ₹1.52 Lakh (net margin 0.4%) and EBITDA of ₹54.41 Lakh (EBITDA margin 15.7%) for FY 2025, as per its filed financial statements.
The GSTIN of Axelus Pharma is 24AARCA6705G1ZN, registered in Gujarat.
The CIN (Corporate Identification Number) of Axelus Pharma is U24239GJ2018PTC105580. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axelus Pharma was incorporated on 12 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Axelus Pharma by revenue are Pharmed Medicare Private Limited, Antila Wellness Private Limited, Sanum Sanguineas Solutions Private Limited, Radicals Pharma Private Limited, P.S Surgical Private Limited and 5 more, all in the Pharma industry (Formulations).
Haribhai Popatbhai Kukadiya ceased to be Additional Director on 29 Sep 2024. Haribhai Popatbhai Kukadiya was appointed as Director on 10 Apr 2024. Bhailalbhai Khodabhai Bhesaniya was appointed as Director on 21 Jan 2019. Axelus Pharma has 7 board changes on record in total.
The registered office of Axelus Pharma is at Plot No. 3401A Phase – 3 G.I.D.C Panoli, Ankleshwer, Gujarat, India – 394115.
Axelus Pharma has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh.